MORPHINE SULFATE
| Brand name | ARYMO ER |
|---|---|
| Active ingredient | MORPHINE SULFATE |
| Strength | 15MG |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | January 2017 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9549899 | July 2033 | product |
| 9044402 | July 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.